-
PublishedNovember 26, 2021
U.S. restricts travel from southern Africa as world races to contain new ‘omicron’ COVID variant
Omicron's actual risks are not understood, but early evidence suggests it carries an increased risk of reinfection compared with other highly transmissible variants.
-
PublishedNovember 24, 2021
State will use federal funds to give bonuses to direct care workers
The federal government has approved Maine's request to use $126 million in American Recovery Act funding to give bonuses to new and existing workers providing home- and community-based health services.
-
PublishedNovember 16, 2021
Boosters for all adults in U.S. closer with panel meeting set
An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available as early as this weekend
-
PublishedNovember 16, 2021
Pfizer asks U.S. regulators to approve promising anti-COVID-19 pill
It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19.
-
PublishedNovember 14, 2021
New record set Sunday for COVID hospitalizations in Maine
The state's 249 hospitalizations surpass the previous high of 248 set Friday. The number of patients in critical care has also increased.
-
PublishedNovember 10, 2021
Maine’s COVID-19 infections keep climbing as virus spreads among the unvaccinated
Two hospitals serving parts of the state with lower vaccination rates have seen the number of patients with the virus spike to the highest levels since the pandemic began.
-
PublishedNovember 9, 2021
Pfizer asks FDA to approve COVID-19 booster shots for all adults
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine since September.
-
PublishedNovember 4, 2021
U.K. authorizes Merck’s antiviral pill, first shown to treat COVID-19
The drug, molnupiravir, was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease.
-
PublishedOctober 29, 2021
FDA clears the way for Pfizer COVID-19 vaccinations for children ages 5-11
On Tuesday, advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterward.
-
PublishedOctober 29, 2021
U.S. intelligence agencies don’t expect to determine origins of COVID-19
A White House-ordered review does, however, say that analysts do not believe the virus was developed as a bioweapon and that most agencies conclude it was not genetically engineered.
- ← Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 102
- Next Page →